The CU DRC contains four biomedical cores that provide services and resources to investigators. These cores are designed to facilitate and broaden CU DRC research by expanding access to shared equipment, enhancing availability and training for emerging technologies, and allowing scientists to have greater access to clinical tissue and data.
Providing researchers with access to an integrated, campus-wide research registry, enabling informatics-based clinical studies.
Providing access to human islets, rodent islet isolation and transplantation services, tissue perifusion, diabetes related histology services, and commonly used cell lines.
Providing access to state-of-the-art multicolor confocal microscopy, flow cytometry analysis and cell sorting services, as well as expert assistance with mass cytometry and ion-beam imaging technologies.
Providing transgenic mouse models and access to and training in human stem cells technologies for in vivo and in vitro disease modeling of diabetes. The core also provides molecular core services including karyotyping, pluripotency assessment, STR fingerprinting, SNP analysis, mycoplasma testing, user operated sequencing platforms, and droplet PCR.
Click here to see a list of the current operational research cores supported by the School of Medicine and the research leadership on the Anschutz Medical Campus.